Skip to Content

Book Chapters

  • Tang DG, Diglio CA, Honn KV. 12(S)-HETE-induced microvascular endothelial cell retraction is mediated by cytoskeletal rearrangement dependent on PKC activation. In: Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. (Nigam S, Honn KV, Marnett LJ, Walden TL, eds), Kluwer Academic Publishers, Boston, pp 219-229, 1992.
  • Taylor JD, Timar J, Tang DG, Bazaz R, Chopra H, Kimler V, Honn KV. 12(S)-HETE induces cytoskeletal phosphorylations and rearrangement in melanoma cells. In: Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. (Nigam S, Honn KV, Marnett LJ, Walden TL, eds), Kluwer Academic Publishers, Boston, pp 635-638, 1992.
  • Honn KV, Tang DG, Chen Y. Adhesion molecules and site-specific metastasis. In: Thrombosis: An Update. (Neri Serneri SS, Gensini GF, Abbate R, Prisco D, eds) Scientific Press, Florence, pp 269-303, 1992.
  • Tang DG, Honn KV. Eicosanoids and tumor cell metastasis. In: Prostaglandin Inhibitors in Tumor Immunology and Immunotherapy. (Harris JE, Braun DP, Anderson KM, eds), CRC press, pp 73-108, 1994.
  • Honn KV, Chen YQ, Tang DG. Interactions among platelets, tumor cells and the vessel wall. In: Principles of Cell Adhesion. (Steiner M, Richardson PD, eds), CRC press, Boca Raton, pp 317-335, 1994.
  • Tang DG, Honn KV, Taylor JD, Porter AT. Dual regulatory role of cyclooxygenase and lipoxygenase and their products in cell survival and apoptosis. In: Frontiers in Bioactive Lipids- 96. (J.Y. Vanderhoek, ed.). Plenum Press, pp 133-139, 1996.
  • Honn KV, Tang DG. Eicosanoid 12(S)-HETE upregulates endothelial cell avb3 integrin expression and promotes tumor cell adhesion to vascular endothelium. Adv. Exp. Med. Biol. 400:766-774, 1997.
  • Tang DG, Honn KV. Role of protein kinase C and phosphatase in 12(S)-HETE-induced tumor cell cytoskeletal reorganization. Adv. Exp. Med. Biol. 400:349-361, 1997.
  • Timar J, Bazaz R, Tang DG, Kimler V, Taylor JD, Honn KV. Post-translational regulation of surface integrin expression in tumor cells by 12-(S)-HETE. Adv. Exp. Med. Biol 400:757-763, 1997.
  • Tang DG, Porter AT, Honn KV. Critical Role of Arachidonate Lipoxygenases in Regulating Apoptosis. Adv. Exp. Med. Biol. 407:405-411, 1997.
  • Raff M, Apperly J, Kondo T, Tokumoto Y, Tang DG. Timing cell-cycle exit and differentiation in oligodendrocyte development. Novartis Found. Symp. 237:100-107, 2001.
  • Choy G, Liu J-W, Chandra D, and Tang DG. Cell survival signaling during apoptosis: Implications in drug resistance and anti-cancer therapeutic development. In: Progress in Drug Research: Advances in Targeted Cancer Therapy. (Schultz RM, ed). 63: 115-145, 2005.
  • Tang DG and Kehrer JP. Carcinogenesis – Balance between apoptosis survival pathways. In: Apoptosis, Cell Signaling, and Human Diseases: Molecular Mechanisms. (Srivastava R, ed). Humana Press. Vol 1, pp 97-117, 2006.
  • Patrawala L and Tang DG. CD44 as a functional cancer stem cell marker and therapeutic target. In: Progress in Gene Therapy: Autologous and Cancer Stem Cell Gene Therapy. (Bertolotti R, Ozawka K, eds). World Scientific Publishers, Singapore. Vol 3, pp 317-334, 2008.
  • Qin JC and Tang DG. Cancer stem cells: A definition. In: Stem Cells and Cancer (Dittmar T, Zaenker KS, eds). Nova Science Publishers, Inc. New York. pp 1-9, 2008.
  • Tang DG. Stem-like cancer cell. In:Encyclopedia of Cancer, 2nd edition. (Schwab M, ed). Springer-Verlag, Berlin, Heidelberg, New York. pp 2827-2830, 2009.
  • Li HW and Tang DG. Prostate cancer stem cells and their involvement in metastasis. In: Current Clinical Oncology: From Local Invasion to Metastatic Cancer: (Leong S PL, ed). Humana Press, New York. pp 455-461, 2009.
  • Honorio S, Li H, and Tang DG. Prostate cancer stem/progenitor cells. In: Cancer Drug Discovery and Development: Stem Cells and Cancer. (Bagley RG and Teicher BA, eds). Humana Press.
    pp 217-230, 2009.
  • Chandra D and Tang DG. Detection of apoptosis in cell-free systems. In: Apoptosis: Methods Mole. Biol. (Erhardt P, ed). Humana Press. 559: 65-75, 2009.
  • Li HW, Jiang M, Honorio S, Patrawala L, Jeter C, Calhoun-Davis T, Hayward SW, and Tang DG. Methodologies in assaying prostate cancer stem cells. In: Methods Mol. Biol. (Yu JS, ed). Humana Press. 569: 85-138, 2009.
  • Yan H, Qin J and Tang DG. Cancer stem cells: potential mediators of therapeutic resistance and novel targets of anti-cancer treatments. In: Pharmaceutical Perspectives of Cancer Therapeutics. (Liu Y and Mahato RI, eds). AAPS-Springer. pp 559-579, 2009.
  • Jeter CR and Tang DG. Prostate cancer stem cells. In: Cancer Stem Cells. (Farrar W, ed). Cambridge University Press. pp 15-30, 2010.
  • Qin J and Tang DG. Prostate cancer stem cells. In: Cancer Stem Cells. (Guan XY, ed). Transworld Research Network. pp 37-56, 2010
  • Jeter C and Tang DG. Prostate tissue stem cells and prostate cancer progression. In:  Stem Cells - From Biology to Therapy.  (RA Meyers, ed).  Wiley-VCH Verlag GmbH & Co.  KGaA.  pp 655-675, 2013.
  • Chen X and Tang DG.  Prostate cancer stem cells:  A brief review.  In:  Stem Cells and Prostate Cancer.  (Cramer S, ed).  Springer, New York, NY.  pp 37-50, 2013.